About Inhibitex (NASDAQ:INHX)
Inhibitex, Inc. develops antibody-based products for the treatment and prevention of bacterial and fungal infections. The Company produces products that can be used as vaccines, binding inhibitors or separation supports for affinity purifications. The Company's lead product candidate, Veronate, which entered into Phase III clinical trial in the second half of 2004, is being developed for the prevention of hospital-associated infections in premature, very low birth weight, (VLBW) infants.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Inhibitex (NASDAQ:INHX) Frequently Asked Questions
What is Inhibitex's stock symbol?
Inhibitex trades on the NASDAQ under the ticker symbol "INHX."
Who are some of Inhibitex's key competitors?
Some companies that are related to Inhibitex include Apple (AAPL), Alphabet (GOOGL), Alphabet (GOOG), Amazon.com (AMZN), Microsoft (MSFT), Facebook (FB), Intel (INTC), Cisco Systems (CSCO), Comcast (CMCSA), PepsiCo (PEP), Netflix (NFLX), Nvidia (NVDA), Amgen (AMGN), Adobe Systems (ADBE), Booking (BKNG), Texas Instruments (TXN), Broadcom (AVGO) and Gilead Sciences (GILD).
Has Inhibitex been receiving favorable news coverage?
Press coverage about INHX stock has been trending somewhat negative this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Inhibitex earned a news impact score of -0.06 on Accern's scale. They also assigned news articles about the healthcare company an impact score of 45.64 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
How do I buy shares of Inhibitex?
Shares of INHX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Inhibitex?
Inhibitex's mailing address is 9005 Westside Pkwy, ALPHARETTA, GA 30009-4783, United States. The healthcare company can be reached via phone at +1-678-7461100.
MarketBeat Community Rating for Inhibitex (INHX)MarketBeat's community ratings are surveys of what our community members think about Inhibitex and other stocks. Vote "Outperform" if you believe INHX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INHX will underperform the S&P 500 over the long term. You may vote once every thirty days.
Inhibitex (NASDAQ:INHX) Analyst Ratings History
(Data available from 4/23/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Inhibitex (NASDAQ:INHX) Earnings History and Estimates Chart
Inhibitex (NASDAQ INHX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Inhibitex (NASDAQ:INHX) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Inhibitex (NASDAQ INHX) Insider Trading and Institutional Ownership History
Inhibitex (NASDAQ INHX) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Inhibitex (NASDAQ INHX) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Inhibitex (NASDAQ:INHX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Inhibitex (NASDAQ:INHX) Income Statement, Balance Sheet and Cash Flow Statement
Inhibitex (NASDAQ INHX) Stock Chart for Monday, April, 23, 2018